☆ 4.7 Article

Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells

PHARMACEUTICS (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

In silico peptide-based therapeutics against human colorectal cancer by the activation of TLR5 signaling pathways

Md. Rubel Hossen et al.

JOURNAL OF MOLECULAR MODELING (2023)

Add to Collection

Review Oncology

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma

Zhao Liu et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer type with high metastatic properties and difficulty in early diagnosis. Most PDAC patients have glucose metabolism disorders, which are closely related to the initiation, development, invasion, and metastasis of PDAC. This review provides valuable insights into the clinical and molecular impacts of glycolysis on PDAC research and treatment.

CANCERS (2023)

Add to Collection

Article Biology

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

Kexin Li et al.

Summary: Osteosarcoma (OS), a primary bone cancer, can be treated using protein-based therapy derived from mesenchymal stem cells (MSCs). The study discovered that activating PKA can convert MSCs into induced tumor-suppressing cells (iTSCs). Administering a conditioned medium (CM) collected from MSCs inhibited tumor-induced bone destruction and showed synergistic effects with cisplatin in a mouse model. The CM was enriched with proteins like calreticulin and PCOLCE, which acted as extracellular tumor suppressors by interacting with CD47 and amyloid precursor protein respectively.

ELIFE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Comparison of in vitro scratch wound assay experimental procedures

Wilhelmina E. Radstake et al.

Summary: In this study, two wound creation techniques were compared, as well as the influence of analysis software and cortisol on fibroblast migration behavior. Results showed that using a cell exclusion method significantly reduced fibroblast migration, while addition of cortisol only affected migration in scratched fibroblast monolayers. The potential relationship to cytokine expression was discussed.

BIOCHEMISTRY AND BIOPHYSICS REPORTS (2023)

Add to Collection

Article Medicine, Research & Experimental

Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis

Kexin Li et al.

Summary: By inhibiting the AMPK signaling, we generated a conditioned medium from lymphocytes and monocytes that can eliminate tumors. The application of this medium was found to inhibit mammary tumor growth and prevent bone loss. Proteins enriched in the medium were found to suppress tumor formation.

THERANOSTICS (2023)

Add to Collection

Article Medicine, Research & Experimental

Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling

Xun Sun et al.

Summary: This study demonstrates that activating the Wnt signaling pathway in osteoblasts can lead to the generation of tumor-suppressive secretomes that inhibit breast cancer growth and protect bone. The findings suggest a counterintuitive approach to treating breast cancer-associated bone metastasis.

THERANOSTICS (2022)

Add to Collection

Review Oncology

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy

Niklas Sturm et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a challenging cancer to treat due to late diagnosis and poor prognosis. Various molecules have been identified as biomarkers, providing potential for early diagnosis and therapeutic prediction. Progress has been made in predicting therapy response with biomarkers, but early detection and recurrence still require further research.

CANCERS (2022)

Add to Collection

Article Multidisciplinary Sciences

Deciphering the immunopeptidome in vivo reveals new tumour antigens

Alex M. Jaeger et al.

Summary: This study engineered an inducible affinity tag into the mouse MHC-I gene to precisely isolate MHC-I peptides from autochthonous pancreatic ductal adenocarcinoma and lung adenocarcinoma in vivo. It revealed that peptide presentation in lung adenocarcinoma is not predictable by mRNA expression or translation efficiency and may be driven by post-translational mechanisms. Vaccination with peptides presented by lung adenocarcinoma induced CD8(+) T cell responses.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity

Wanjia Tian et al.

Summary: ALDOA, an enzyme involved in glycolysis and gluconeogenesis, plays a significant role in tumor metabolism. This study explored the overall roles of ALDOA in pan-cancer using databases and online analysis tools. The expression of ALDOA was found to be higher in lung adenocarcinoma, liver hepatocellular carcinoma, and head and neck squamous cell carcinoma compared to normal tissues. Increased ALDOA expression often indicated a worse prognosis for patients. The correlation between ALDOA and immune infiltration varied among different tumors, and ALDOA was found to be associated with macrophage, CD4+ T cell, and CD8+ T cell infiltration.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Oncology

Generation of the Chondroprotective Proteomes by Activating PI3K and TNFα Signaling

Xun Sun et al.

Summary: By activating oncogenic and inflammatory signaling, we have generated chondroprotective proteomes. Hsp90ab1 and GAPDH play important roles in this process. These findings provide new insights into the treatment of chondrosarcoma and inflammatory arthritis.

CANCERS (2022)

Add to Collection

Article Immunology

SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK

Sona Aramyan et al.

Summary: Pulmonary surfactant protein A (SP-A) is an immune-protective collagenous lectin in the lung that binds to immune cells and opsonizes infectious agents. It has been found that SP-A may bind to the S protein of SARS-CoV-2, interfering with viral entry into cells.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Mining the Immunopeptidome for Antigenic Peptides in Cancer

Ricardo A. Leon-Letelier et al.

Summary: The immunopeptidome of cancer cells is a potential resource for immunotherapy, as it can lead to the discovery of novel cancer-specific antigens. These immunopeptides may contain protein post-translational modifications that are often overlooked by genomic and transcriptomic analysis. We discuss how this information can be utilized to develop cancer vaccines.

CANCERS (2022)

Add to Collection

Review Oncology

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

Amy H. Tang et al.

Summary: Triple-negative breast cancer (TNBC) is the most aggressive subtype and predominantly affects BRCA mutation carriers and young women, particularly African American women. Novel treatment strategies and research initiatives are needed to overcome uncertainties in predicting chemoresistance and tumor relapse. The activation of the EGFR-K-RAS-SIAH pathway is a major driver in chemoresistant TNBC, and SIAH has the potential to become a novel tumor-specific, therapy-responsive, and prognostic biomarker.

CANCER DRUG RESISTANCE (2022)

Add to Collection

Article Medicine, Research & Experimental

Counterintuitive production of tumor-suppressive secretomes from Oct4-and c-Myc-overexpressing tumor cells and MSCs

Kexin Li et al.

Summary: This study employed a counterintuitive approach of overexpressing Yamanaka factors in tumor cells and MSCs, which generated anti-tumor secretomes and inhibited the progression of mammary tumors and tumor-induced bone loss. The study also identified potential extracellular tumor suppressors and revealed the underlying regulatory mechanism.

THERANOSTICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer

Alexandre F. Aissa et al.

Summary: Tyrosine kinase inhibitors have clinical effectiveness in treating certain subsets of cancers with receptor tyrosine kinase somatic mutations, but limited duration of response and development of drug resistance are common issues. Single-cell RNA sequencing revealed multiple cancer cell subpopulations with epigenetic changes and variable therapeutic sensitivity. Overrepresented gene ontologies associated with drug tolerance include epithelial-to-mesenchymal transition, drug metabolism, and vesicle transport. Combination therapy targeting specific drug tolerant cell subpopulations shows promise in inhibiting drug resistance.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Endocrinology & Metabolism

Suppression of cancer-associated bone loss through dynamic mechanical loading

G. M. Pagnotti et al.

Summary: Patients with cancer face elevated fracture risk and susceptibility to osteoporosis, making exercise and mechanical loading crucial for bone health during treatment. Dysregulation caused by cancer cells and metabolic dysfunction can adversely affect musculoskeletal tissues, highlighting the importance of understanding mechanotransduction pathways. Studies suggest a positive impact of exercise and mechanical loading on tumor-bearing skeletal tissues, emphasizing the need for non-pharmacological approaches in cancer treatment.

BONE (2021)

Add to Collection

Article Oncology

Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells

Ke-Xin Li et al.

Summary: By activating Wnt signaling, the conditioned medium derived from osteoclasts can be transformed into a bone-protective, tumor-inhibiting agent, which suppresses tumor growth and bone loss.

CANCERS (2021)

Add to Collection

Article Multidisciplinary Sciences

EGFR activation limits the response of liver cancer to lenvatinib

Haojie Jin et al.

Summary: Inhibition of EGFR is synthetically lethal with lenvatinib in liver cancer, and the combination of lenvatinib with the EGFR inhibitor gefitinib shows potent anti-proliferative effects both in vitro and in vivo. This combination therapy could be a promising strategy for HCC patients with high levels of EGFR, providing meaningful clinical responses.

NATURE (2021)

Add to Collection

Article Cell Biology

Spectral Analysis of ATP-Dependent Mechanical Vibrations in T Cells

Ishay Wohl et al.

Summary: Mechanical vibrations in cells are influenced by ATP consumption and Myosin II activity, and can be differentiated through spectral analysis. Specific frequency ranges, such as 0-3 Hz and 100-150 Hz, indicate dominant mechanical work in intracellular components. These vibrations could have implications in immune synapse formation and immune evasion by malignant cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Oncology

Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial

Aparna R. Parikh et al.

Summary: The study suggests that combining radiation with immune checkpoint blockade may have some efficacy in treating MSS colorectal cancer and pancreatic cancer, demonstrating the feasibility of this approach. It also found that higher numbers of natural killer cells and repetitive RNA transcription are correlated with disease control in patients.

NATURE CANCER (2021)

Add to Collection

Article Medicine, Research & Experimental

Generation of the tumor-suppressive secretome from tumor cells

Shengzhi Liu et al.

Summary: The study found that tumor cells can also produce anti-tumor secretomes, which have inhibitory effects on various types of cancer and have the potential to be a treatment option for primary and metastatic cancers. In a mouse model, it was discovered that the tumor-suppressive secretome can reduce tumor growth and prevent bone destruction, with the protein Eno1 interacting with CD44 playing a role in its anti-tumor effects.

THERANOSTICS (2021)

Add to Collection

Article Medicine, Research & Experimental

Preventing tumor progression to the bone by induced tumor-suppressing MSCs

Xun Sun et al.

Summary: By overexpressing specific genes, iTS MSCs demonstrated the potential to inhibit tumor growth and suppress mammary tumors and bone osteolysis through induced MSC CM. Additionally, the presence of atypical tumor suppressors in the MSC CM contributed to the inhibition of tumor cell growth.

THERANOSTICS (2021)

Add to Collection

Review Oncology

The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities

Won Jin Ho et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis

Jonathan M. Ghergurovich et al.

CANCER RESEARCH (2020)

Add to Collection

Article Chemistry, Physical

Mechanical Responses of Breast Cancer Cells to Substrates of Varying Stiffness Revealed by Single-Cell Measurements

Fang Tian et al.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Application of liquid biopsy for surgical management of pancreatic cancer

Minako Nagai et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

Add to Collection

Article Oncology

Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival

Yu-Chan Chang et al.

CANCER RESEARCH (2019)

Add to Collection

Article Cell Biology

In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis

Jordi Pijuan et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Add to Collection

Review Oncology

Pancreatic cancer-A disease in need: Optimizing and integrating supportive care

Gordon T. Moffat et al.

CANCER (2019)

Add to Collection

Article Oncology

Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

Lilian Schwarz et al.

BMC CANCER (2018)

Add to Collection

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Chemistry, Analytical

Continuous and simultaneous measurement of the biophysical properties of blood in a microfluidic environment

Yang Jun Kang

ANALYST (2016)

Add to Collection

Article Biochemistry & Molecular Biology

CancerPPD: a database of anticancer peptides and proteins

Atul Tyagi et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Article Multidisciplinary Sciences

Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance

Qiang Zuo et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Oncology

Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts

Aarif Ahsan et al.

NEOPLASIA (2014)

Add to Collection

Article Multidisciplinary Sciences

Fine Tuning of Tissues' Viscosity and Surface Tension through Contractility Suggests a New Role for α-Catenin

Tomita Vasilica Stirbat et al.

PLOS ONE (2013)

Add to Collection

Review Microbiology

From antimicrobial to anticancer peptides. A review

Diana Gaspar et al.

FRONTIERS IN MICROBIOLOGY (2013)

Add to Collection

Article Oncology

Identification of novel MAGE-A6-and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay

Yasuto Akiyama et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)

Add to Collection

Article Medicine, Research & Experimental

5-Ethynyl-2′-Deoxyuridine Labeling Detects Proliferating Cells in the Regenerating Avian Cochlea

Christina L. Kaiser et al.

LARYNGOSCOPE (2009)

Add to Collection

Article Oncology

Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1

Hidenobu Ishizaki et al.

CLINICAL CANCER RESEARCH (2006)

Add to Collection

Review Pharmacology & Pharmacy

Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment

Jamie S. Mader et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)

Add to Collection

Article Oncology

Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2

S Wada et al.

CANCER RESEARCH (2005)

Add to Collection

Review Biochemical Research Methods

Imaging technologies for the detection of multiple stains in proteomics

K Miura

PROTEOMICS (2003)

Add to Collection

Article Biophysics

The effects of osmotic stress on the viscoelastic and physical properties of articular chondrocytes

F Guilak et al.

BIOPHYSICAL JOURNAL (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.